FDA inspection
Maiva Pharma Private Limited: FDA inspection ending Oct 29, 2022
FDA inspection 1190383 · Voluntary Action Indicated (VAI) · Hosur
Key facts
| Inspection ID | 1190383 |
|---|---|
| Firm | Maiva Pharma Private Limited |
| FEI number | 3014362214 |
| Address | No 32 Sipcot Industrial Complex, Phase I |
| City | Hosur |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Oct 29, 2022 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data